Treatment effects of apremilast for Behcet's disease: a systematic review and meta-analysis
Not Applicable
- Conditions
- Behcet's disease
- Registration Number
- JPRN-UMIN000044257
- Lead Sponsor
- Yokohama City University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Patients not fulfilled Behcet's disease diagnostic criteria
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method BDCAF and presence of BD-related symptoms after 12 weeks of apremilast treatment
- Secondary Outcome Measures
Name Time Method